RT Journal Article
SR Electronic
T1 SARS-CoV-2 and human milk: what is the evidence?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.07.20056812
DO 10.1101/2020.04.07.20056812
A1 Lackey, Kimberly A.
A1 Pace, Ryan M.
A1 Williams, Janet E.
A1 Bode, Lars
A1 Donovan, Sharon M.
A1 Järvinen, Kirsi M.
A1 Seppo, Antti E.
A1 Raiten, Daniel J.
A1 Meehan, Courtney L.
A1 McGuire, Mark A.
A1 McGuire, Michelle K.
YR 2020
UL http://medrxiv.org/content/early/2020/04/20/2020.04.07.20056812.abstract
AB The novel coronavirus SARS-CoV-2 has emerged as one of the most compelling and concerning public health challenges of our time. To address the myriad issues generated by this pandemic, an interdisciplinary breadth of research, clinical, and public health communities has rapidly engaged to collectively find answers and solutions. One area of active inquiry is understanding the mode(s) of SARS-CoV-2 transmission. While respiratory droplets are a known mechanism of transmission, other mechanisms are likely. Of particular importance to global health is the possibility of vertical transmission from infected mothers to infants through breastfeeding or consumption of human milk. However, there is limited published literature related to vertical transmission of any human coronaviruses (including SARS-CoV-2) via human milk and/or breastfeeding. Results of the literature search reported here (finalized on April 17, 2020) revealed a single study providing some evidence of vertical transmission of human coronavirus 229E; a single study evaluating presence of SARS-CoV in human milk (it was negative); and no published data on MERS-CoV and human milk. We identified 12 studies reporting human milk tested for SARS-CoV-2; one study detected the virus in one milk sample, and another study detected SARS-CoV-2 specific IgG in milk. Importantly, none of the studies on coronaviruses and human milk report validation of their collection and analytical methods for use in human milk. These reports are evaluated here, and their implications related to the possibility of vertical transmission of coronaviruses (in particular, SARS-CoV-2) during breastfeeding are discussed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no funding associated with this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis manuscript represents a review of existing literature, no data has been generated.